Nanomedicine Volume IIA

The safety effectiveness and utility of medical nanorobotic devices will critically depend upon their biocompatibility with human organs tissues cells and biochemical systems. In this Volume we broaden the definition of nanomedical biocompatibility to include all of the mechanical physiological immunological cytological and biochemical responses of the human body to the introduction of artificial medical nanodevices whether “particulate” (large doses of independent micron-sized individual nanorobots) or “bulk” (nanorobotic organs assembled either as solid objects or built up from trillions of smaller artificial cells or docked nanorobots inside the body) in form.